Scarica l'app Stockscreener
4.1996
2.43%
0.0896
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.11
Aprire:
$4.15
Volume 24 ore:
223.19K
Relative Volume:
0.22
Capitalizzazione di mercato:
$806.09M
Reddito:
$12.99M
Utile/perdita netta:
$-74.39M
Rapporto P/E:
-9.5445
EPS:
-0.44
Flusso di cassa netto:
$-78.92M
1 W Prestazione:
-3.00%
1M Prestazione:
-5.61%
6M Prestazione:
+34.08%
1 anno Prestazione:
+8.51%
Intervallo 1D:
$4.10
$4.21
Intervallo di 1 settimana:
$4.10
$4.535
Portata 52W:
$2.705
$5.10
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Nome
Arbutus Biopharma Corp
Settore
Industria
Telefono
604-419-3200
Indirizzo
701 VETERANS CIRCLE, WARMINSTER, PA
Confronta ABUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.205 | 787.88M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.94 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-02-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Iniziato | Jefferies | Hold |
| 2020-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-27 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-07-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-03-06 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-05 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Reiterato | B. Riley FBR | Buy |
| 2019-10-04 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2018-10-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-06 | Downgrade | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Ripresa | Chardan Capital Markets | Buy |
| 2018-03-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Reiterato | Wedbush | Outperform |
| 2016-12-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
Mostra tutto
Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie
Can Arbutus Biopharma Corporation stock deliver surprise earnings beat2025 Market Overview & Community Consensus Stock Picks - newser.com
Arbutus Biopharma to Present New Data on Imdusiran and AB-101 at AASLD 2025 - MyChesCo
Is Arbutus Biopharma Corporation stock a buy on dipsMarket Rally & Safe Entry Trade Reports - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving AverageWhat's Next? - MarketBeat
Risk adjusted return profile for Arbutus Biopharma Corporation analyzedPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Arbutus Announces Four Abstracts Accepted for Presentation at AASLDThe Liver Meeting® 2025 - GlobeNewswire
Arbutus Biopharma (ABUS) Showcases Promising Liver Disease Resea - GuruFocus
Has Arbutus Biopharma Corporation formed a bullish divergenceQuarterly Trade Report & Technical Pattern Recognition Alerts - newser.com
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year? - Yahoo Finance
Applying Wyckoff theory to Arbutus Biopharma Corporation stockWeekly Trend Report & Fast Gain Stock Tips - newser.com
Is Arbutus Biopharma Corporation forming a reversal pattern2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Risk vs reward if holding onto Arbutus Biopharma CorporationRate Cut & Real-Time Volume Analysis - newser.com
Statistical indicators supporting Arbutus Biopharma Corporation’s strengthWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Voya Investment Management LLC Sells 4,534 Shares of Arbutus Biopharma Corporation $ABUS - Defense World
Will Arbutus Biopharma Corporation stock deliver better than expected guidanceShort Setup & Long Hold Capital Preservation Plans - newser.com
Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 - MSN
Assenagon Asset Management S.A. Makes New $122,000 Investment in Arbutus Biopharma Corporation $ABUS - Defense World
Is Arbutus Biopharma Corporation reversing from oversold territoryJuly 2025 WrapUp & Fast Gain Stock Tips - newser.com
Arbutus Biopharma Corporation Stock Analysis and ForecastEarnings Miss Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Does Arbutus Biopharma Corporation fit your quant trading modelJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Can machine learning forecast Arbutus Biopharma Corporation recoveryJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Building trade automation scripts for Arbutus Biopharma Corporation2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
What MACD signals say about Arbutus Biopharma Corporation2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
Analyzing drawdowns of Arbutus Biopharma Corporation with statistical tools2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
What machine learning models say about Arbutus Biopharma Corporation2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Arbutus Biopharma Corporation stock volume spike explainedQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Is Arbutus Biopharma Corporation stock bottoming outLong Setup & Weekly Setup with ROI Potential - newser.com
what machine learning models say about arbutus biopharma corporationJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Using economic indicators to assess Arbutus Biopharma Corporation potential2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Aug Setups: Whats next for Arbutus Biopharma Corporation stockLong Setup & Weekly Breakout Watchlists - خودرو بانک
Goldman Sachs Group Inc. Raises Position in Arbutus Biopharma Corporation $ABUS - MarketBeat
Reversal indicators forming on Arbutus Biopharma Corporation stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
Aug Rallies: Is Arbutus Biopharma Corporation stock a top performer YTD2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
RSI Check: Should I set a stop loss on RELYMarket Performance Report & Free Community Consensus Stock Picks - خودرو بانک
Arbutus: IP Drama With High Stakes (NASDAQ:ABUS) - Seeking Alpha
Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):